Quintiles Appoints Oren Cohen to Senior Vice President, Clinical Research Strategies
Oren Cohen, MD, promoted to Quintiles' senior vice president of clinical research strategies
Research Triangle Park, NC-April 16, 2008-Quintiles Transnational (www.quintiles.com) today announced the appointment of Oren Cohen, MD, as senior vice president, clinical research strategies.
Most recently, Cohen held the position of chief medical and scientific officer. In his new role, Cohen will be responsible for evaluating and implementing new clinical research strategies, part of the company's "shape the future" objective. He also will continue to serve as managing director of Quintiles public health and government services.
Cohen is also a consulting professor of medicine at Duke University School of Medicine. He earned a medical degree from Duke University and completed his residency at New York Hospital/Cornell University Medical Center and his fellowship in infectious diseases at the National Institutes of Health. He is board-certified in internal medicine and infectious diseases and has written more than 50 scientific articles and book chapters. He is a fellow of the Infectious Diseases Society of America and serves as a reviewer for several highly respected medical journals. He has won numerous awards for his professional achievements and has presented his work at dozens of conferences around the world.
Unifying Industry to Better Understand GCP Guidance
May 7th 2025In this episode of the Applied Clinical Trials Podcast, David Nickerson, head of clinical quality management at EMD Serono; and Arlene Lee, director of product management, data quality & risk management solutions at Medidata, discuss the newest ICH E6(R3) GCP guidelines as well as how TransCelerate and ACRO have partnered to help stakeholders better acclimate to these guidelines.
Beyond the Molecule: How Human-Centered Design Unlocks AI's Promise in Pharma
June 23rd 2025How human-centered AI that is focused on customer, user, and employee experience can drive real transformation in clinical trials and beyond by aligning intelligent technologies with the people who use them.
2025 DIA Annual Meeting: Why AI and Automation Are Set to Become the New Normal in Clinical Research
June 20th 2025Peter Ronco, CEO, Emmes, shares his long-term vision for artificial intelligence in clinical research, from making automation routine to improving drug discovery, transforming regulatory oversight, reducing animal testing, and promoting ethical, equitable data use worldwide.
